Drugs@FDA: FDA-Approved Drugs
Company: AZURITY
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
E.E.S. | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | AB | Yes | No |
ERYPED | ERYTHROMYCIN ETHYLSUCCINATE | EQ 400MG BASE/5ML | GRANULE;ORAL | Prescription | AB | Yes | Yes |
ERYPED | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | AB | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/02/1965 | ORIG-1 | Approval | UNKNOWN |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/23/2018 | SUPPL-74 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050207s074,050611s036lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/050207Orig1s074,050611Orig1s036ltr.pdf | |
08/17/2017 | SUPPL-73 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050207s073lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/050207Orig1s073ltr.pdf |
02/02/2012 | SUPPL-71 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050207s071lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/050207s071,050611s035ltr.pdf | |
12/10/2008 | SUPPL-68 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050297s030,050207s068lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050207s068, 050297s030ltr.pdf | |
11/04/2010 | SUPPL-67 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/050207s067,050297s029ltr.pdf |
05/22/2008 | SUPPL-66 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050207s066ltr.pdf |
01/05/2008 | SUPPL-65 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050207s065lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050207s065ltr.pdf | |
01/26/2011 | SUPPL-64 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050207s064lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/050207s064ltr.pdf | |
03/12/2004 | SUPPL-61 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50611slr024,50297slr024,50207slr061ltr.pdf |
08/10/2006 | SUPPL-58 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050207s058,050297s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/050207s058, 050297s021LTR.pdf | |
04/25/2002 | SUPPL-57 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/50207s057.pdf |
11/24/1999 | SUPPL-56 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
02/04/2000 | SUPPL-55 | Labeling |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/50-207s054s055_Erythromycin.cfm |
02/04/2000 | SUPPL-54 | Labeling |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/50-207s054s055_Erythromycin.cfm |
05/09/1997 | SUPPL-53 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
04/29/1997 | SUPPL-52 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
04/14/1997 | SUPPL-51 | Labeling |
Label is not available on this site. |
||
04/14/1997 | SUPPL-50 | Labeling |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
04/23/2018 | SUPPL-74 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050207s074,050611s036lbl.pdf | |
08/17/2017 | SUPPL-73 | Labeling-Package Insert | Label (PDF) | Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050207s073lbl.pdf |
02/02/2012 | SUPPL-71 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050207s071lbl.pdf | |
01/26/2011 | SUPPL-64 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050207s064lbl.pdf | |
12/10/2008 | SUPPL-68 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050297s030,050207s068lbl.pdf | |
01/05/2008 | SUPPL-65 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050207s065lbl.pdf | |
08/10/2006 | SUPPL-58 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050207s058,050297s021lbl.pdf |
E.E.S.
GRANULE;ORAL; EQ 200MG BASE/5ML
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
E.E.S. | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | Yes | AB | 050207 | AZURITY |
ERYPED | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | Yes | AB | 050207 | AZURITY |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 211204 | AMNEAL PHARMS |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 062055 | ANI PHARMS |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 062055 | ANI PHARMS |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 216212 | CADILA PHARMS LTD |
ERYPED
GRANULE;ORAL; EQ 400MG BASE/5ML
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ERYPED | ERYTHROMYCIN ETHYLSUCCINATE | EQ 400MG BASE/5ML | GRANULE;ORAL | Prescription | Yes | AB | 050207 | AZURITY |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 400MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 211204 | AMNEAL PHARMS |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 400MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 062055 | ANI PHARMS |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 400MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 216212 | CADILA PHARMS LTD |
GRANULE;ORAL; EQ 200MG BASE/5ML
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
E.E.S. | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | Yes | AB | 050207 | AZURITY |
ERYPED | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | Yes | AB | 050207 | AZURITY |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 211204 | AMNEAL PHARMS |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 062055 | ANI PHARMS |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 062055 | ANI PHARMS |
ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL | Prescription | No | AB | 216212 | CADILA PHARMS LTD |